Targeting ß2 adrenergic receptors regulate human T cell function directly and indirectly.

Area of Science:

• Immunology
• Neuroimmunology
• Pharmacology

Background:

• Central nervous system activation influences immune cells via catecholamines acting on beta-2 adrenergic receptors (ß2AR).
• Previous research often used non-specific cell stimulation, lacking focus on antigen-specific responses and distinguishing direct vs. indirect ß2AR effects on T cells and antigen-presenting cells (APCs).

Purpose of the Study:

• To investigate the impact of salmeterol (Sal), a selective ß2AR agonist, on antigen-specific T cell responses (IFN-γ production) and cytotoxic cell killing.
• To elucidate the direct and indirect effects of ß2AR stimulation on T cells and APCs.

Main Methods:

• Stimulation of T cells and APCs with Cytomegalovirus lysate, pp65 peptides, or Staphylococcal enterotoxin B.
• Assessing IFN-γ production in CD4 and CD8 T cells following salmeterol or epinephrine treatment.
• Evaluating cytotoxic cell killing using the CD107a assay with target cells (T-CHO, K562).

Main Results:

• Salmeterol reduced IFN-γ(+) CD4 and CD8 T cells, with stronger inhibition in CD8 T cells, via a ß2AR-dependent pathway.
• Salmeterol suppressed cytotoxicity of CD8 T cells and NK cells, with NK cells showing greater inhibition than CD8 T cells.
• Both direct and indirect (via APCs) ß2AR stimulation inhibited inflammatory cytokine production and cytotoxic activity.

Conclusions:

• Targeting ß2AR on lymphocytes and APCs inhibits inflammatory cytokine production and cytotoxic cell killing.
• A hierarchy of inhibition exists, with CD8 T cells and NK cells being more sensitive to ß2AR-mediated suppression than CD4 T cells.